NAT10 Polyclonal Antibody, Cy5.5 Conjugated
Product Specifications
Background
Has protein acetyltransferase activity in vitro. Can acetylate both histones and microtubules. Histone acetylation may regulate transcription and mitotic chromosome de-condensation. Activates telomerase activity by stimulating the transcription of TERT, and may also regulate telomerase function by affecting the balance of telomerase subunit assembly, disassembly, and localization. Acetylates alpha-tubulin, which may affect microtubule stability and cell division.
Synonyms
ALP; hALP; KIAA1709; N acetyltransferase 10; N acetyltransferase 10 GCN5 related; N acetyltransferase like; N acetyltransferase like protein; N-acetyltransferase 10; NAT10; NAT10_HUMAN; NET43.
Gene ID
55226
Cellular Locus
Nucleus
Host
Rabbit
Cross Reactivity
Rat
Immunogen
51-150/1025
Target
NAT10
Clonality
Polyclonal
Isotype
IgG
Conjugation
Cy5.5
Source
KLH conjugated synthetic peptide derived from human NAT10
Applications
IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
675nm/694nm
Concentration
1µg/µl
Dilution
IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
55226
Predicted Cross Reactivity
Human, Mouse, Dog, Cow, Sheep, Pig, Horse, Chicken
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6209693-01 0.1 mL
DRP-2 (Dihydropyrimidinase Related Protein-2, CRMP-2, Collapsin Response Mediator Protein 2,N2A3, Unc-33-like Phosphoprotein 2, ULIP-2, DPYSL2, CRMP2, ULIP2) (MaxLight 550)
Ask
View Details 
MBS6209693-02 5x 0.1 mL
DRP-2 (Dihydropyrimidinase Related Protein-2, CRMP-2, Collapsin Response Mediator Protein 2,N2A3, Unc-33-like Phosphoprotein 2, ULIP-2, DPYSL2, CRMP2, ULIP2) (MaxLight 550)
Ask
View Details 
